In this study, we investigated how human genetic differences might affect the immune responses to malaria. Specifically, we looked at how certain genetic variations in the TLR9 gene, which is part of the immune system, might affect the production of antibodies against malaria proteins in 210 Venezuelan individuals infected with Plasmodium vivax, one of the parasites that causes malaria. Most of these individuals were male miners likely infected in a highly endemic area. Our findings suggest that people with a specific genetic variation, known as a heterozygous genotype in the TLR9 gene, had different levels of antibodies against two malaria proteins. Interestingly, those with higher antibody levels had fewer symptoms, suggesting that a stronger immune response may protect against malaria symptoms. Understanding these genetic influences on immune response could be valuable in designing vaccines and treatments that work more effectively in different populations.